Friday, December 2, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Derivative

CHICAGO - Shareholders claim Abbott Laboratories execs profited handsomely while hurting shareholders through illegal off-label marketing of Depakote, which cost the company a $1.3 billion settlement with the USA and 24 states.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.